I don’t think we should be worried about posts regarding a buyout at a certain price per or what is being deleted here. I have had posts deleted for asking the tough questions regarding trxc so it goes both ways here.
One thing we can be certain is a buyout will not happen anytime soon and I am pretty confident members from this board can understand that. Right now the hurdles for trxc will be sales, getting a handle the burn rate and restructuring the 17 mil in debt. Keep in mind Senhance has been given FDA approval and no longer considered an R&D company so all eyes will be on sales. Based on the very dismal sales over the last few years I don’t understand how things will change going forward.
News 
Market Data 
Discover 
